Impact of guideline directed medical therapy on myocardial function in adults with congenital heart disease

Carley Bright,Afshan Rizvi,Francis Ezekwueme,Mary Schiff,Jennifer Kliner,Morgan Hindes,Kyla Thorn,Vanessa Kowalski,Patricia Hovanec,Ashley Draxinger,Melissa Costa,Natasha Wolfe,Tarek Alsaied,Adam Christopher,Jacqueline Kreutzer,Sunil Patel,Arvind Hoskoppal,Samir Saba,Laura Olivieri,Bryan H Goldstein,Anita Saraf
DOI: https://doi.org/10.1016/j.ijcard.2024.132413
2024-11-01
Abstract:Background: Guideline-directed heart failure therapy with angiotensin receptor blocker/neprilysin inhibitor (ARNi) and sodium-glucose transporter inhibitors (SGLT2i) has been incrementally beneficial in improving outcomes in heart failure patients. Objective: Evaluate the feasibility and efficacy of guideline-directed medical therapy (GDMT) in adults congenital heart disease (ACHD) patients. Methods: In a retrospective cohort study, ACHD patients with either New York Heart Association (NYHA) Class II symptoms or systemic ejection fraction (EF) <45%, optimized on a combination of beta-blocker (BB), ARNi, mineralocorticoid receptor antagonist (MRA) and SGLT2i were evaluated. Results: Forty-six patients with a mean age 42.6 ± 12.1 years prescribed GDMT were identified. Twenty-eight (61%) were male, 20 (43%) had a systemic right ventricle (RV) and 9 (20%) had single-ventricle physiology. Over the optimization period, 20 (43%) were sustained on ARNi and 42 (91%) on SGLT2i in addition to treatment with BB and MRA. Over a period of 45 weeks, echocardiography parameters for left ventricle (LV) ejection fraction (EF) (+7.5%, p = 0.006), systemic ventricle (SV) velocity time integral (VTI) (+1.9 cm, p = 0.012) and LV global longitudinal strain (GLS) (-2.5%, p = 0.005) improved when 3-4 medications were used versus 1-2 medications alone. The use of either ARNi or SGLT2i (+8.1%, p = 0.017) or in combination (+7.0%, p = 0.043) increased LVEF compared to the use of neither medication. Conclusion: Combination GDMT is beneficial in improving myocardial characteristics in ACHD patients with systemic RV and LV.
What problem does this paper attempt to address?